279 related articles for article (PubMed ID: 26986236)
1. Determinants of early life immune responses to RSV infection.
Ruckwardt TJ; Morabito KM; Graham BS
Curr Opin Virol; 2016 Feb; 16():151-157. PubMed ID: 26986236
[TBL] [Abstract][Full Text] [Related]
2. Vaccine Induced Herd Immunity for Control of Respiratory Syncytial Virus Disease in a Low-Income Country Setting.
Kinyanjui TM; House TA; Kiti MC; Cane PA; Nokes DJ; Medley GF
PLoS One; 2015; 10(9):e0138018. PubMed ID: 26390032
[TBL] [Abstract][Full Text] [Related]
3. Mucosal vaccines against respiratory syncytial virus.
Yang K; Varga SM
Curr Opin Virol; 2014 Jun; 6():78-84. PubMed ID: 24794644
[TBL] [Abstract][Full Text] [Related]
4. New insights for development of a safe and protective RSV vaccine.
Blanco JC; Boukhvalova MS; Shirey KA; Prince GA; Vogel SN
Hum Vaccin; 2010 Jun; 6(6):482-92. PubMed ID: 20671419
[TBL] [Abstract][Full Text] [Related]
5. Passive and active immunization against respiratory syncytial virus for the young and old.
Villafana T; Falloon J; Griffin MP; Zhu Q; Esser MT
Expert Rev Vaccines; 2017 Jul; 16(7):1-13. PubMed ID: 28525961
[TBL] [Abstract][Full Text] [Related]
6. Impairment of T cell immunity by the respiratory syncytial virus: targeting virulence mechanisms for therapy and prophylaxis.
González PA; Bueno SM; Riedel CA; Kalergis AM
Curr Med Chem; 2009; 16(34):4609-25. PubMed ID: 19903147
[TBL] [Abstract][Full Text] [Related]
7. Host response to respiratory syncytial virus infection.
Arruvito L; Raiden S; Geffner J
Curr Opin Infect Dis; 2015 Jun; 28(3):259-66. PubMed ID: 25887611
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary immunity and immunopathology: lessons from respiratory syncytial virus.
Olson MR; Varga SM
Expert Rev Vaccines; 2008 Oct; 7(8):1239-55. PubMed ID: 18844597
[TBL] [Abstract][Full Text] [Related]
9. A novel respiratory syncytial virus (RSV) F subunit vaccine adjuvanted with GLA-SE elicits robust protective TH1-type humoral and cellular immunity in rodent models.
Lambert SL; Aslam S; Stillman E; MacPhail M; Nelson C; Ro B; Sweetwood R; Lei YM; Woo JC; Tang RS
PLoS One; 2015; 10(3):e0119509. PubMed ID: 25793508
[TBL] [Abstract][Full Text] [Related]
10. Respiratory syncytial virus in infants: is maternal vaccination a realistic strategy?
Munoz FM
Curr Opin Infect Dis; 2015 Jun; 28(3):221-4. PubMed ID: 25918956
[TBL] [Abstract][Full Text] [Related]
11. The use of a neonatal mouse model to study respiratory syncytial virus infections.
Cormier SA; You D; Honnegowda S
Expert Rev Anti Infect Ther; 2010 Dec; 8(12):1371-80. PubMed ID: 21133663
[TBL] [Abstract][Full Text] [Related]
12. Development of innate and adaptive immunity to RSV in young children.
Parsons EL; Kim JS; Malloy AMW
Cell Immunol; 2024; 399-400():104824. PubMed ID: 38615612
[TBL] [Abstract][Full Text] [Related]
13. Inferior immunogenicity and efficacy of respiratory syncytial virus fusion protein-based subunit vaccine candidates in aged versus young mice.
Cayatte C; Snell Bennett A; Rajani GM; Hostetler L; Maynard SK; Lazzaro M; McTamney P; Ren K; O'Day T; McCarthy MP; Schneider-Ohrum K
PLoS One; 2017; 12(11):e0188708. PubMed ID: 29182682
[TBL] [Abstract][Full Text] [Related]
14. Formulation of the respiratory syncytial virus fusion protein with a polymer-based combination adjuvant promotes transient and local innate immune responses and leads to improved adaptive immunity.
Sarkar I; Garg R; van Drunen Littel-van den Hurk S
Vaccine; 2016 Sep; 34(42):5114-5124. PubMed ID: 27591951
[TBL] [Abstract][Full Text] [Related]
15. Identifying targets in the hunt for effective respiratory syncytial virus interventions.
Tayyari F; Hegele RG
Expert Rev Respir Med; 2012 Apr; 6(2):215-22. PubMed ID: 22455493
[TBL] [Abstract][Full Text] [Related]
16. Biology of Infection and Disease Pathogenesis to Guide RSV Vaccine Development.
Boyoglu-Barnum S; Chirkova T; Anderson LJ
Front Immunol; 2019; 10():1675. PubMed ID: 31402910
[TBL] [Abstract][Full Text] [Related]
17. Host proteome correlates of vaccine-mediated enhanced disease in a mouse model of respiratory syncytial virus infection.
van Diepen A; Brand HK; de Waal L; Bijl M; Jong VL; Kuiken T; van Amerongen G; van den Ham HJ; Eijkemans MJ; Osterhaus AD; Hermans PW; Andeweg AC
J Virol; 2015 May; 89(9):5022-31. PubMed ID: 25694607
[TBL] [Abstract][Full Text] [Related]
18. Immunopathology of RSV infection: prospects for developing vaccines without this complication.
van Drunen Littel-van den Hurk S; Mapletoft JW; Arsic N; Kovacs-Nolan J
Rev Med Virol; 2007; 17(1):5-34. PubMed ID: 17004293
[TBL] [Abstract][Full Text] [Related]
19. Respiratory syncytial virus (RSV) vaccines--two steps back for one leap forward.
Power UF
J Clin Virol; 2008 Jan; 41(1):38-44. PubMed ID: 18340669
[TBL] [Abstract][Full Text] [Related]
20. Consequences of immature and senescent immune responses for infection with respiratory syncytial virus.
Malloy AM; Falsey AR; Ruckwardt TJ
Curr Top Microbiol Immunol; 2013; 372():211-31. PubMed ID: 24362692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
